Lung Cancer News at Annual Meeting 2016: Continued Focus on Immunotherapy

Description: What is the latest news on lung cancer immunotherapies? On location at ASCO 2016, lung cancer expert Dr. Charu Aggarwal of the University of Pennsylvania Hospital gives an update. Dr. Aggarwal gives a brief glimpse at the results of combination immunotherapy data, including crizotinib (Xalkori) and alectinib (Alecensa).

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Follow on Google+ |
Shared By : P2Professional
Posted on : 06/20/16
Added : 3 years ago